Clinical Trial Update: Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating single-dose iloperidone in patients with mild to moderate hepatic impairment compared with healthy volunteers. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Fanapt (iloperidone)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hepatic Impairment | Phase 1 | Status: COMPLETED